SRS Capital Advisors »

Alnylam Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.0M 13k 456.00
2025-06-30 $49k 150 326.09
2025-03-31 $23k 85 270.04
2024-12-31 $113k 481 235.31
2024-09-30 $133k 485 275.03
2024-06-30 $117k 481 243.00
2023-12-31 $4.0k 21 191.43
2023-09-30 $1.4k 8 177.20
2023-06-30 $570 3 190.00
2023-03-31 $1.6k 8 200.38
2022-12-31 $1.9k 8 237.63
2022-09-30 $2.0k 8 250.00